A National Decision Point: Effective Testing and Screening for Covid-19

A National Decision Point - Effective Testing and Screening for Covid-19

White Paper

A National Decision Point: Effective Testing and Screening for Covid-19

Published date

September 9, 2020

A new Duke-Margolis report out provides a framework for public health officials and community leaders in schools, businesses and other institutions on how to use Covid-19 screening test strategies to operate safely and prevent further spread of the virus. A National Decision Point: Effective Testing and Screening for Covid-19, was developed with funding from the Rockefeller Foundation, and aims to be a useful tool to help officials customize screening strategies of asymptomatic people to local circumstances and risk – with a particular focus on higher-risk populations and suppressing community spread.

Image

"Today’s report from @RockefellerFdn & @DukeMargolis emphasizes the critical relationship between degree of community spread and need for testing; smart mitigation policy + smart testing = pandemic control." ADM Brett P. Giroir, Asst Secretary for Health

A National Decision Point: Effective Testing and Screening for Covid-19

Duke-Margolis Authors

silcox

Christina Silcox, PhD

Research Director, Digital Health
Adjunct Assistant Professor
Senior Team Member
Margolis Core Faculty

Mark McClellan

Mark McClellan, MD, PhD

Director of the Duke-Margolis Institute for Health Policy
Robert J. Margolis, MD, Professor of Business, Medicine and Policy
Margolis Executive Core Faculty